Est in 1983, Dishman Carbogen Amcis Ltd is a company with strong process R&D to late stage clinical & commercial mfg & supply of API to pharma companies.
Ahmedabad, Gujarat - INDIA
Joined March 2021
- Tweets386
- Following67
- Followers208
- Likes186
IMDCAL (Dishman Carbogen Amcis) retweeted
NIPER Ahmedabad and Dishman Carbogen Amcis Ltd. (one of the leading API and Custom Synthesis Companies) have entered into a Memorandum of Understanding (MoU) for collaboration in academics and research activities.
@NIPERAHM @imdcal @Pharmadept @JPNadda @AnupriyaSPatel
IMDCAL (Dishman Carbogen Amcis) retweeted
As inflation pinches pharma industry on all fronts, @imdcal Dishman Carbogen is looking to raise product prices further, CFO Harshil Dalal tells @InformistMedia in an #exclusive #interview
Dishman Carbogen is looking to raise product prices again as costs rise, Global CFO Harshil Dalal tells @InformistMedia in an #Interview. Read on…
#Pharma #Chemicals
informistmedia.com/chome/dis…
IMDCAL (Dishman Carbogen Amcis) retweeted
Dishman Carbogen Amcis Ltd announces successful results on Clinical Research Study that reveals positive response in vitamin D deficiency/insufficiency in patients with COVID-19.
CARBOGEN AMCIS provided the Active Pharmaceutical Ingredient (Calcifediol). carbogen-amcis.com/newsitems…
IMDCAL (Dishman Carbogen Amcis) retweeted
CARBOGEN AMCIS announces successful FDA inspection of its facility in Aarau, Switzerland. The pre-approval paper inspection for an intermediate product from a customer was concluded successfully, confirming that no on-site inspection is required. Read more carbogen-amcis.com/newsitems…
IMDCAL (Dishman Carbogen Amcis) retweeted
@imdcal trades higher on planning to invest $50 million in France to set up new facility
investmentguruindia.com/Stoc…
#StockMarket #PharmaSector #DishmanCarbogenAmcis #Investmentguruindia
IMDCAL (Dishman Carbogen Amcis) retweeted
Dishman Group to invest USD 50 mn for setting up drug manufacturing facility in France
zeebiz.com/companies/news-di…
IMDCAL (Dishman Carbogen Amcis) retweeted
Dishman Carbogen to focus on developing niche molecules in oncology ift.tt/3AREQcU
IMDCAL (Dishman Carbogen Amcis) retweeted
#DCAL
Dishman Carbogen looks like it has been in a strong accumulation zone since past few weeks is breaking out today with strong volumes. A close above 235 will confirm the BO.
IMDCAL (Dishman Carbogen Amcis) retweeted
Dishman Carbogen back on investor radar amid hopes of recovery #ETMarkets #MarketsNews #BizNews #MarketsUpdate ift.tt/3aexsgK
IMDCAL (Dishman Carbogen Amcis) retweeted
Slide from my #Biotechnology webinar delivered last month. Globally, very few players have this incredibly complex capability to develop ADCs.
Disclaimer: logos shown were for academic purpose only. There was no investment advice on any business.
IMDCAL (Dishman Carbogen Amcis) retweeted
Dishman Carbogen Amcis announces results of study on treatment for Vitamin D deficiency - bit.ly/3oCRxUl
bit.ly/3oCRxUl
IMDCAL (Dishman Carbogen Amcis) retweeted
Dishman Carbogen Amcis Ltd announces successful results from the partnership with Boston University School of Medicine on study that uncovers treatment for vitamin D deficiency
#DCAL #DishmanCarbogenAmcis #VitaminDDeficiency
equitybulls.com/admin/news20…
IMDCAL (Dishman Carbogen Amcis) retweeted
DISHMAN CARBOGEN AMCIS: CO ANNOUNCES THAT ITS SUBSIDIARY, CARBOGEN AMCIS AG HAS ENTERED INTO A CO-INVESTMENT AGREEMENT OF MORE THAN CHF 15M WITH A KEY CLIENT TO EXPAND SWISS SITE
IMDCAL (Dishman Carbogen Amcis) retweeted
CARBOGEN AMCIS AG has entered into a co-investment agreement of more than CHF 15 million with a key client to expand Swiss site
#CarbogenAMCISAG #DCAL
equitybulls.com/admin/news20…
